We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$32.6B
| $317K | ﹤0.01% |
+3,100
| New | +$315K |
|
2927
Alto Ingredients
ALTO
$338M
| $316K | ﹤0.01% |
46,313
-28,027
| -38% | -$157K |
|
2928
iShares Global Materials ETF
MXI
$337M
| $316K | ﹤0.01% |
+3,367
| New | +$303K |
|
2929
Bioceres Crop Solutions
BIOX
$20.4M
| $315K | ﹤0.01% |
23,060
+14,306
| +163% | +$189K |
|
|
ABST
2930
DELISTED
Absolute Software Corp
ABST
| $314K | ﹤0.01% |
+37,010
| New | +$314K |
|
|
LGTY
2931
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $312K | ﹤0.01% |
15,005
-8,989
| -37% | -$199K |
|
2932
Comstock Resources
CRK
$3.66B
| $311K | ﹤0.01% |
+23,803
| New | +$212K |
|
|
TPIC
2933
DELISTED
TPI Composites
TPIC
| $311K | ﹤0.01% |
22,075
+7,466
| +51% | +$95.2K |
|
2934
Amplify BlueStar Israel Technology ETF
ITEQ
$111M
| $310K | ﹤0.01% |
+5,524
| New | +$305K |
|
|
2935
PUT
Microsoft
MSFT
$2.91T
| $309K | ﹤0.01% |
1,000
-84,300
| -99% | -$25.4M |
|
2936
Philips
PHG
$25.2B
| $309K | ﹤0.01% |
+12,259
| New | +$335K |
|
|
2937
CALL
Microsoft
MSFT
$2.91T
| $308K | ﹤0.01% |
1,000
-21,500
| -96% | -$6.47M |
|
2938
Stevanato
STVN
$5.55B
| $305K | ﹤0.01% |
15,207
-9,689
| -39% | -$169K |
|
|
PNT
2939
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $304K | ﹤0.01% |
38,110
+33,240
| +683% | +$211K |
|
2940
BlackSky Technology
BKSY
$876M
| $303K | ﹤0.01% |
+20,133
| New | +$421K |
|
|
GPGI
2941
GPGI Inc
GPGI
$4.05B
| $303K | ﹤0.01% |
+48,109
| New | +$299K |
|
2942
Clarus
CLAR
$126M
| $302K | ﹤0.01% |
+13,235
| New | +$307K |
|
2943
nCino
NCNO
$2.03B
| $302K | ﹤0.01% |
+7,367
| New | +$337K |
|
2944
Booz Allen Hamilton
BAH
$8.53B
| $300K | ﹤0.01% |
+3,418
| New | +$281K |
|
2945
Erie Indemnity
ERIE
$12.8B
| $300K | ﹤0.01% |
1,702
-19,396
| -92% | -$3.48M |
|
2946
Bridgewater Bancshares
BWB
$584M
| $299K | ﹤0.01% |
17,867
+542
| +3% | +$9.44K |
|
2947
Kulicke & Soffa
KLIC
$4.43B
| $298K | ﹤0.01% |
5,314
-20,220
| -79% | -$1.12M |
|
|
EQRX
2948
DELISTED
EQRx, Inc. Common Stock
EQRX
| $298K | ﹤0.01% |
71,807
+15,264
| +27% | +$66.4K |
|
2949
Paymentus
PAY
$4.35B
| $294K | ﹤0.01% |
+13,950
| New | +$344K |
|
|
PETWW
2950
CALL
DELISTED
Wag! Group Co Warrant
PETWW
| $293K | ﹤0.01% |
29,388
| – | – |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.